Capsule

How it happened

Capsule is a New York-based digital pharmacy that delivers prescriptions to customers' doors. Pandemic-era demand propelled it past a $1B valuation in April 2021 with a $300M Series D from Durable Capital, T. Rowe Price, Whale Rock and Baillie Gifford. As growth stalled in the 2022-23 downturn, it cut about 13% of staff and raised a Series E in early 2023 at roughly half its $1.2B peak — a steep down round. Glassdoor reviews from that period tracked the shift from blitz-expansion to belt-tightening: repeated layoff rounds that left remaining staff covering extra workloads, and couriers describing successive cuts to pay and mileage incentives as the company chased profitability.

Employee accounts paraphrase anonymous, unverified reviews posted publicly on Glassdoor ↗. See our methodology.